RxDoctor Payments Data

Varun Sambhariya, MD

Orthopaedic Surgery of the Spine · York, PANPI 1366947350

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $4,180 of the $6,283 with a category attached, or 66.5%. 7 manufacturers reported payments, led by Synthes GmbH at 38.4% of the total. Reporting peaked in 2024 at $2,660 and has fallen 53.4% since, to $1,239 in 2025. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in PA, where the typical reported total is $6,283.

$6,283in general payments, 2019–2025

Across 38 payments — averaging $165.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Synthes GmbH$2K
  • Globus Medical$2K
  • Pylant Medical$634
  • Johnson & Johnson$611
  • Stryker$347
  • Boston Scientific$97
  • plus $47 from 1 others

What the payments were for

  • Travel & lodging$4,18067%
  • Food & beverage$1,49324%
  • Education$61010%

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,283 in reported general payments places this provider in the 50th percentile of 43 orthopaedic surgery of the spine providers in Pennsylvania.

See all orthopaedic surgery of the spine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$40,979
Medicare patients
152
Services billed
521

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl12$68
Meloxicam12$30

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in York

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →